CME Group
Price: 263.80Company and Business Model
CME Group operates as a global markets company, providing trading and clearing services across various asset classes, including derivatives, options, and futures. Its core products encompass commodities, financials, and equity indices. Major business segments include the CME, CBOT, NYMEX, and COMEX exchanges. The primary revenue sources are transaction fees, market data services, and clearing services, driven by trading volumes and market activity.
Investment Profile
The investment profile of CME Group is characterized by a balanced approach, appealing to investors seeking both growth and income through dividends. The company offers a competitive dividend yield, alongside potential for capital appreciation driven by market activity. This profile suits investors with a medium to long-term horizon, looking for stability and moderate risk.
Fundamental metrics (experimental)
- EPS (TTM) — earnings per share for the last 12 months, $
- 11.80 OK
- Revenue QoQ — quarter-over-quarter revenue growth
- 14.0% ↑
- EPS surprise
- 0.7% in line
- 20d volatility
- 2.3% stable
- Dividend yield
- 3.7% moderate last ex-date: 2026-03-10
Track in portfolio
Price chart
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-06-11 05:16 | Sell | Buy | Mixed momentum; solid fundamentals but recent volatility. |
| 2026-05-28 02:39 | Hold | Sell | Weak momentum and high risk outweigh dividend yield benefits. |
| 2026-05-24 02:35 | Buy | Hold | Solid fundamentals, but mixed momentum signals present risks. |
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-04-23 13:24 | Morgan Stanley | Target Lowered | 362 → 353 | 282.445 |
| 2026-04-23 10:13 | Barclays | Target Lowered | 343 → 316 | 285.71 |
| 2026-04-10 10:51 | Morgan Stanley | Target Raised | 340 → 362 | 294.815 |